Jun 28, 2018

Steven Pavletic, M.D., Senior Clinician in the Experimental Transplantation and Immunology Branch, has been elected as a corresponding member of the Croatian Academy of Sciences and Arts. Dr. Pavletic was honored during a ceremony on June 14 at the Palace of the Academy in Zagreb, Croatia. Read more...

Jun 26, 2018

The Center for Cancer Research has been at the forefront in the field of immunology and immunotherapy for decades. Our scientists have made seminal findings that have opened doors to new research areas and treatment approaches for cancer patients. Use this timeline to explore our rich history at the cutting edge of research towards understanding the immune system and harnessing its power to treat cancer. Read more...

May 29, 2018

Twenty-five years ago, NCI scientists uncovered the VHL gene, a gene whose mutation can lead to the development of kidney tumors. The discovery, the result of a decade-long partnership between CCR scientists, including W. Marston Linehan, M.D., Chief of CCR’s Urologic Oncology Branch, and families affected by the disease, paved the way for new targeted therapies that have improved the prognosis for patients with advanced kidney cancers.  Read more...

May 23, 2018

Please join us for a Facebook Live on adult brain and spine tumor research and treatment May 25 at 11:00 a.m. ET.. The conversation will focus on primary central nervous system (CNS) tumors, meaning the tumor begins in the brain or spinal cord. Mark Gilbert, M.D., Chief, and Terri Armstrong, M.D., Senior Investigator, both from the Neuro-Oncology Branch, will be joined by moderator and Chief Executive Officer, David Arons, of the National Brain Tumor Society.  Read more...

Apr 23, 2018

The U.S. Food and Drug Administration granted orphan drug status in February to selumetinib for use in patients with the genetic disorder neurofibromatosis type 1 (NF1), who often develop tumors of the peripheral nervous system. Receiving orphan drug designation is a helpful step for selumetinib. Read more...

Apr 19, 2018

The Center for Cancer Research has been at the forefront of cancer research for decades. Spanning the spectrum from basic research to advances in clinical care, including the development of new cancer drugs and innovative vaccines, Landmarks highlights the remarkable discoveries that have occurred at CCR over the years.  Read more...

Apr 2, 2018

The Annual Meeting of the American Association for Cancer Research (AACR) covers the latest basic, translational, clinical and prevention-focused cancer research in the field. The 2018 AACR Annual Meeting —“Driving Innovative Cancer Science to Patient Care” — will take place on April 14-18 in Chicago and feature presentations from several CCR scientists. View the list of CCR presentations at AACR…

Mar 30, 2018

March 30th marks the annual observation of National Doctors Day.  Learn more...

Mar 29, 2018

Over 50 global thought-leaders gathered in early March to discuss and identify the most important research questions in Merkel cell carcinoma (MCC). Read more...

Mar 26, 2018

Every year, the Center for Cancer Research makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. The CCR’s annual publication, Milestones, features select research highlights from the past year to illustrate the quality and spectrum of our work in the basic and clinical sciences. Read the 2017-18 issue of Milestones…